Skip to content Search the desk⌘ Ctrl K Agent Sign in I Inmune Bio Inc.
I INMB Inmune Bio Inc.
I INMB Inmune Bio Inc.
Earnings When Inmune Bio Inc. reports, what it reported each quarter, and how the stock took the results.
35 quarters. Mar 31, 2018 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 8 filings.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Mar 1 – Apr 1 Quarter by quarter 3 years 5 years 10 years
Revenue Net income EPS Operating income Operating cash flow Free cash flow
Q4 2025 · derived $ 0 . 0 0 $0.00 No Q4 2024 on file
Q3 2026 Nov 5, 2026, after the close
Revenue — —
Net income -$4.72M N/M
EPS -$0.17 N/M Q2 2026 Aug 6, 2026, after the close
Inmune Bio Inc. · CIK 1711754 · Engraved from SEC EDGAR
Revenue
—
— Q1 2026 May 7, 2026, after the close0.3% by the close of May 8
Revenue — —
Net income -$5.41M N/M
EPS -$0.20 N/M Q4 2025 Mar 30, 2026, after the close0.9% by the close of Mar 31
Revenue $0.00 —
Net income -$5.26M N/M
EPS — —
Results day Typical move ±5.4% A typical move of 5.4% either way
Up after 4 of 12, down after 8.
−11.5% −8.8% −6.8%
When it reports
Usual day Varies
After quarter end 32 to 38 days
10-Q filed 31 to 38 days over its last 8
10-K filed 62 to 88 days over its last 8 ended Sep 30, 2024 · filed Oct 31, 2024 · 31 d ended Dec 31, 2024 · filed Mar 27, 2025 · 86 d ended Mar 31, 2025 · filed May 8, 2025 · 38 d ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d ended Sep 30, 2025 · filed Oct 30, 2025 · 30 d ended Dec 31, 2025 · filed Mar 30, 2026 · 89 d FY 2026 Q3 2026 Sep 30, 2026 — Nov 5, 2026 36 d 10-Q — — -$0.17 5.1% Q2 2026 Jun 30, 2026 — Aug 6, 2026 37 d 10-Q — — -$0.05 +9.7% Q1 2026 Mar 31, 2026 — May 7, 2026 37 d 10-Q — — -$0.20 0.3%
FY 2025 Q4 2025 derived Dec 31, 2025 — Mar 30, 2026 89 d 10-K $0.00 — — 0.9% Q3 2025 Sep 30, 2025 Oct 30, 2025 · after-hours Oct 30, 2025 30 d 10-Q $0.00 — -$0.24 +5.8% Q2 2025 Jun 30, 2025 Aug 7, 2025 · after-hours Aug 7, 2025 38 d 10-Q $0.00 — -$1.05 8.2% Q1 2025 Mar 31, 2025 May 8, 2025 · after-hours May 8, 2025 38 d 10-Q $50.00K +257.1% -$0.43 1.7%
FY 2024 Q4 2024 derived Dec 31, 2024 Mar 27, 2025 · after-hours Mar 27, 2025 86 d 10-K $0.00 −100.0% — +1.5% Q3 2024 Sep 30, 2024 — Oct 31, 2024 31 d 10-Q $0.00 −100.0% -$0.60 +3.2% Q2 2024 Jun 30, 2024 — Aug 1, 2024 32 d 10-Q $0.00 −100.0% -$0.50 — Q1 2024 Mar 31, 2024 — May 9, 2024 39 d 10-Q $14.00K −63.2% -$0.61 —
FY 2023 Q4 2023 derived Dec 31, 2023 — Mar 28, 2024 88 d 10-K $28.00K −71.1% — 6.8% Q3 2023 Sep 30, 2023 Nov 1, 2023 · after-hours Nov 1, 2023 32 d 10-Q $43.00K −56.1% -$0.48 — Q2 2023 Jun 30, 2023 — Aug 7, 2023 38 d 10-Q $46.00K +187.5% -$0.36 8.8% Q1 2023 Mar 31, 2023 — May 3, 2023 33 d 10-Q $38.00K −76.7% -$0.36 —
FY 2022 Q4 2022 derived Dec 31, 2022 — Mar 2, 2023 61 d 10-K $97.00K −40.5% — 11.5% Q3 2022 Sep 30, 2022 Nov 2, 2022 · after-hours Nov 2, 2022 33 d 10-Q $98.00K +600.0% -$0.43 +7.8% Q2 2022 Jun 30, 2022 Aug 3, 2022 · after-hours Aug 3, 2022 34 d 10-Q $16.00K — -$0.38 +2.6% Q1 2022 Mar 31, 2022 — May 5, 2022 35 d 10-Q $163.00K +3,975.0% -$0.39 8.1%
FY 2021 Q4 2021 derived Dec 31, 2021 — Mar 3, 2022 62 d 10-K $163.00K — — — Q3 2021 Sep 30, 2021 — Nov 3, 2021 34 d 10-Q $14.00K — -$0.55 — Q2 2021 Jun 30, 2021 — Aug 4, 2021 35 d 10-Q $0.00 — -$0.44 +5.8% Q1 2021 Mar 31, 2021 — May 5, 2021 35 d 10-Q $4.00K — -$0.32 6.2%
FY 2020 Q4 2020 derived Dec 31, 2020 — Mar 4, 2021 63 d 10-K — — — — Q3 2020 Sep 30, 2020 — Nov 5, 2020 36 d 10-Q — — -$0.36 6.5% Q2 2020 Jun 30, 2020 — Aug 5, 2020 36 d 10-Q — — -$0.20 9.6% Q1 2020 Mar 31, 2020 — May 14, 2020 44 d 10-Q — — -$0.19 0.4%
FY 2019 Q4 2019 derived Dec 31, 2019 — Mar 11, 2020 71 d 10-K — — — 10.8% Q3 2019 Sep 30, 2019 — Nov 8, 2019 39 d 10-Q — — -$0.28 0.2% Q2 2019 Jun 30, 2019 — Aug 9, 2019 40 d 10-Q $0.00 — -$0.04 11.4% Q1 2019 Mar 31, 2019 — May 15, 2019 45 d 10-Q $0.00 — -$0.20 —
FY 2018 Q4 2018 derived Dec 31, 2018 — Mar 29, 2019 88 d 10-K — — — — Q3 2018 Sep 30, 2018 — — — — — — -$0.18 — Q2 2018 Jun 30, 2018 — — — — $0.00 — -$0.71 — Q1 2018 Mar 31, 2018 — — — — $0.00 — -$0.33 —
Earlier years, FY 2018 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
May 7, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Revenue $0.00 Revenue, change from a year earlier: Q4 2025 n/m, Q3 2025 n/m, Q2 2025 n/m, Q1 2025 +257.1% +257.1% n/m n/m n/m
Net income -$5.26M Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m n/m n/m n/m n/m
EPS — EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m n/m n/m n/m n/m 5.1% by the close of Nov 6
+9.7% by the close of Aug 7
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2026 · filed May 7, 2026 · 37 d ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d ended Sep 30, 2026 · filed Nov 5, 2026 · 36 d window Mar 1 – Apr 1 · projected The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: −11.5% after Q4 2022.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks